Posters

Do “Nurse Interventions” Positively Impact both Behavioral and Clinical Outcomes in Patients with Diabetes?

August 21, 2018

AUTHORS: Rice D., Coumel S., Monteil C., Murray E., Lewis S.Z., Egbuonu-Davis L. CONFERENCE: American Association of Diabetes Educators -AADE DATE: August 17-20, 2018. Objective(s): To examine applications and interventions used by nurses to improve clinical and behavioral outcomes in diabetes. 2018-AADE-DRE-Sanofi-Endo-046-Poster See poster

The Importance of Patient Satisfaction with Insulin Device Administration: Does a Positive Experience Drive Improved Diabetes Self-Management and Adherence?

August 21, 2018

AUTHORS: Rice D., Liska J., Beaudin M, Del Aguila M., Murray E., Beal A. CONFERENCE: American Association of Diabetes Educators -AADE DATE: August 17-20, 2018 Objective(s): • To compare the patient experience with self-injecting pens and insulin pumps and explore how satisfaction with those devices affects insulin adherence, diabetes self-management and patient health outcomes. 2018-AADE-DRE-Sanofi-Endo-031-Poster See poster

Promoters and Barriers of Engagement in Type 2 Diabetes Mellitus Populations with Real World Technological Interventions

June 27, 2018

AUTHORS: Duvall K., Trasy A., Murray E., Milam R, Sayre T, Beal A. CONFERENCE: ADA 2018 DATE: June 22-26, 2018. Objective(s): This review aims to evaluate real-world studies that discuss engagement elements of telemedicine/mobile health or web-based technological interventions focusing on T2DM. 2018-ADA-DRE-Sanofi-Poster See poster detail

Comparative Efficacy Of Consolidation Therapy After Chemoradiation Therapy (Crt) In Patients With Unresectable, Stage Iii Non-Small Cell Lung Cancer (Nsclc): A Network Meta-Analysis

May 24, 2018

AUTHORS: Husain F., Harari O., Fazeli M., Zhang Y. CONFERENCE: ISPOR 2018 DATE: May 19-23, 2018. Objectives: This study aims to estimate the comparative clinical efficacy of consolidation therapies after cCRT, by using network meta-analysis (NMA). This current analysis focuses on progression free survival (PFS). See poster 2018-ISPOR-AstraZeneca-Poster

Influenza Vaccination In Diabetes Mellitus: Exploring Patient Burden And Strategies To Increase Uptake

May 23, 2018

AUTHORS: Liska J., Banyon O., Samson S., Whittington C., Murray E., Beal A. CONFERENCE: ISPOR 2018 DATE: May 19-23, 2018. Objective(s): Explore the benefits of influenza vaccination in the diabetes population and determine characteristics of successful vaccination programs in diabetes and other high-risk populations. Vaccination strategies in higher uptake populations, such as healthcare workers (where vaccination may be mandatory) and […]

Benefits and Risks of Clopidogrel Versus Aspirin Monotherapy for Acute Ischemic Stroke: A Systematic Review and Meta-analysis

April 13, 2018

AUTHORS: Shalini G., Min L., Bo H., Liping L., Dara P., Toby S. CONFERENCE: ESC 2018 DATE: April 11-13, 2018. Objective(s): To conduct a systematic literature review to compare the efficacy and safety of clopidogrel versus aspirin monotherapy in patients with acute ischemic stroke.   See poster 2018-ESC-DRE-Sanofi-Poster

Clinical Outcomes Associated with De-Escalation from Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome

March 13, 2018

AUTHORS: Angiolillo D, Paek D, Shah R, Fazeli MS, Girotra S CONFERENCE: ACC 2018 DATE: March 10-12, 2018. Objective(s): To conduct a systematic literature review to assess the rate of efficacy and safety outcomes following a switch from ticagrelor to clopidogrel therapy in patients with acute coronary syndrome. 2018-ACC-DRE-Sanofi-UF-Poster See poster

Prevalence and Timing of De-Escalation Therapy from Ticagrelor to Clopidogrel in Acute Coronary Syndrome Patients: Results of a Meta-Analysis

March 13, 2018

AUTHORS: Angiolillo D, Paek D, Shah R, Sayre T, Clausel A, Girotra S CONFERENCE: ADA 2018 DATE: March 10-12, 2018. Aim: To conduct a systematic literature review to assess the prevalence rate of de-escalation from ticagrelor to clopidogrel in patients with ACS and to assess the time at which de-escalation takes place following the index event. 2018-ACC-DRE-Sanofi-UF-Poster […]

Transparency Matters: Use of Digital Software Platform in Replicating Published Systematic Literature Reviews and Network Meta-Analyses.

December 9, 2017

AUTHORS: Husain, F., Kuang, Y., Feinman, T., Whittington, C., Sayre, T., del Aguila, M. CONFERENCE: ISPOR 2017 DATE: November 4-8, 2017 Objective(s): This work assessed the transparency and replicability of manual methods with comparison to software-assisted replication for search and analysis of published systematic literature reviews (SLRs) and network meta-analyses (NMAs). See poster 2017-ISPOR-DRE-Poster

Network meta-analysis of iGlarLixi, a fixed-ratio combination GLP-1 RA and basal insulin, versus insulin premix

December 9, 2017

AUTHORS: Sayre T., Shah R., Thomas J., Murray E., Brulle-Wohlhueter C., Shaunik A., Perfetti R. CONFERENCE: IDF Congress 2017 DATE: December 4-8, 2017. Aim: T o better understand the clinical efficacy of iGlarLixi compared with insulin intensification options, especially premix insulins, in patients with T2D inadequately controlled on BI See poster

Network meta-analysis of treatments for type 2 diabetes in patients inadequately controlled on oral antidiabetics

December 9, 2017

AUTHORS: Shah R., Sayre T., Thomas J., Murray E., Brulle-Wohlhueter C., Shaunik A. CONFERENCE: IDF Congress 2017 DATE: December 4-8, 2017. Aim: To better understand the treatment efficacy and safety of fixed-ratio combinations (FRCs) of BI and GLP- 1 RA compared with BI, GLP- 1 RA or OAD monotherapy using network meta-analysis in the absence of head-to-head randomized controlled trials (RCT) See […]

Efficacy and safety of fixed-ratio combination of GLP-1 RA plus BI in type 2 diabetes mellitus: a network meta-analysis

December 9, 2017

AUTHORS: Shah R., Sayre T., Thomas J., Murray E., Brulle-Wohlhueter C., Shaunik A. CONFERENCE: IDF Congress 2017 DATE: December 4-8, 2017. Aim: This review aimed to better understand the safety and efficacy of FRCs of GLP-1 RAs and basal insulin (BI) in comparison with BI, GLP-1 RA, basal-bolus insulin, premix insulin, and free combination GLP-1 RA and BI via […]

Innovative AI-powered technologies to facilitate evidence dissemination to inform medical and healthcare decisions

December 7, 2017

AUTHORS: Lewis S.Z., Feinman F., del Aguila M., Newton M., Battista R.J., Shalev E., Kuiper J. CONFERENCE: 10th Annual Conference on the Science of Dissemination and Implementation in Health DATE: December 4-6, 2017. 2017-DRE-Academy-Health-Poster See poster

Impact of Patient Device Experience on Acceptance and Adherence in Diabetes Mellitus

December 3, 2017

AUTHORS: Liska J., Beaudin M., Rice D., del Aguila M., Murray E., Beal A. CONFERENCE: European Society for Patient Adeherence, Compliance and Persistence- ESPACOMP 2017 DATE: December 4-8, 2017. Aim: To conduct a systematic literature review to examine how the patient experience with self-injectable insulin pen devices for diabetes mellitus impacts treatment acceptance and adherence, […]

Predictors of Flu Vaccine Uptake in Patients with Diabetes Mellitus

December 2, 2017

AUTHORS: Liska J., Banyon O., Samson S., Sayre T., Shah R., Beal A. CONFERENCE: European Society for Patient Adeherence, Compliance and Persistence- ESPACOMP 2017 DATE: November 30- December 2, 2017. Aim: To conduct a systematic literature review to examine how the patient experience with self-injectable insulin pen devices for diabetes mellitus impacts treatment acceptance and adherence, […]

Real-World Incidence of Malignancies, Infections and Auto-Immune Diseases in Persons with Rheumatoid Arthritis Treated with Biological vs. Non-Biological Disease-Modifying Antirheumatic Drugs: A systematic Review and Meta-Analysis

August 31, 2017

AUTHORS: Simon T., Kostelec J., Franek J. CONFERENCE: 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management ICPE 2017 DATE: August 26-30, 2017. Objective(s): To perform a systematic literature review to identify publications reporting the rate of malignancies, autoimmune diseases, and infections for BDMARDs vs. NBDMARDs To determine the comparative incidence of immune-related events through meta-analysis See poster […]